SPRED1 and neoplasm: However SPRED1, a Ras-MAPK pathway gene in the region previously reported to be mutated in AM8 and MM19,33 and reported to act as a tumor suppressor in MM33 was also affected, with 14 tumors having predicted LoF rearrangement events.